These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26300006)

  • 21. Inhibition of Annexin A10 Contributes to ZNF281 Mediated Aggressiveness of Hepatocellular Carcinoma.
    Zhang X; Zhang C; Zhao Q; Wang S; Wang L; Si Y; Su Q; Cheng S; Ding W
    J Hepatocell Carcinoma; 2023; 10():553-571. PubMed ID: 37041757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CircAGFG1 sponges miR-203 to promote EMT and metastasis of non-small-cell lung cancer by upregulating ZNF281 expression.
    Xue YB; Ding MQ; Xue L; Luo JH
    Thorac Cancer; 2019 Aug; 10(8):1692-1701. PubMed ID: 31243884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrophoretic mobility shift assays implicate XRCC2:rs3218550C>T as a potential low-penetrant susceptibility allele for sporadic breast cancer.
    Sirisena ND; Samaranayake N; Dissanayake VHW
    BMC Res Notes; 2019 Aug; 12(1):476. PubMed ID: 31370865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51.
    Silva SN; Tomar M; Paulo C; Gomes BC; Azevedo AP; Teixeira V; Pina JE; Rueff J; Gaspar JF
    Cancer Epidemiol; 2010 Feb; 34(1):85-92. PubMed ID: 20004634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel lncRNA-ZNF281 regulates cell growth, stemness and invasion of glioma stem-like U251s cells.
    Li XT; Li JC; Feng M; Zhou YX; Du ZW
    Neoplasma; 2019 Jan; 66(1):118-127. PubMed ID: 30509101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of aldehyde reductase expression by STAF and CHOP.
    Barski OA; Papusha VZ; Kunkel GR; Gabbay KH
    Genomics; 2004 Jan; 83(1):119-29. PubMed ID: 14667815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A potential role for the XRCC2 R188H polymorphic site in DNA-damage repair and breast cancer.
    Rafii S; O'Regan P; Xinarianos G; Azmy I; Stephenson T; Reed M; Meuth M; Thacker J; Cox A
    Hum Mol Genet; 2002 Jun; 11(12):1433-8. PubMed ID: 12023985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The TMPRSS2-ERG Gene Fusion Blocks XRCC4-Mediated Nonhomologous End-Joining Repair and Radiosensitizes Prostate Cancer Cells to PARP Inhibition.
    Chatterjee P; Choudhary GS; Alswillah T; Xiong X; Heston WD; Magi-Galluzzi C; Zhang J; Klein EA; Almasan A
    Mol Cancer Ther; 2015 Aug; 14(8):1896-906. PubMed ID: 26026052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequence-specific binding of recombinant Zbed4 to DNA: insights into Zbed4 participation in gene transcription and its association with other proteins.
    Mokhonov VV; Theendakara VP; Gribanova YE; Ahmedli NB; Farber DB
    PLoS One; 2012; 7(5):e35317. PubMed ID: 22693546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The diagnostic value of DNA repair gene in breast cancer metastasis.
    Yang Y; Li X; Hao L; Jiang D; Wu B; He T; Tang Y
    Sci Rep; 2020 Nov; 10(1):19626. PubMed ID: 33184404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homologous recombination as a potential target for caffeine radiosensitization in mammalian cells: reduced caffeine radiosensitization in XRCC2 and XRCC3 mutants.
    Asaad NA; Zeng ZC; Guan J; Thacker J; Iliakis G
    Oncogene; 2000 Nov; 19(50):5788-800. PubMed ID: 11126366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term XPC silencing reduces DNA double-strand break repair.
    Despras E; Pfeiffer P; Salles B; Calsou P; Kuhfittig-Kulle S; Angulo JF; Biard DS
    Cancer Res; 2007 Mar; 67(6):2526-34. PubMed ID: 17363570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of homologous recombination DNA repair genes by HDAC inhibition in prostate cancer is mediated through the E2F1 transcription factor.
    Kachhap SK; Rosmus N; Collis SJ; Kortenhorst MS; Wissing MD; Hedayati M; Shabbeer S; Mendonca J; Deangelis J; Marchionni L; Lin J; Höti N; Nortier JW; DeWeese TL; Hammers H; Carducci MA
    PLoS One; 2010 Jun; 5(6):e11208. PubMed ID: 20585447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility.
    Fu YP; Yu JC; Cheng TC; Lou MA; Hsu GC; Wu CY; Chen ST; Wu HS; Wu PE; Shen CY
    Cancer Res; 2003 May; 63(10):2440-6. PubMed ID: 12750264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silencing of MBD1 reverses pancreatic cancer therapy resistance through inhibition of DNA damage repair.
    Xu J; Zhu W; Xu W; Cui X; Chen L; Ji S; Qin Y; Yao W; Liu L; Liu C; Long J; Li M; Yu X
    Int J Oncol; 2013 Jun; 42(6):2046-52. PubMed ID: 23588667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A systematic gene-gene and gene-environment interaction analysis of DNA repair genes XRCC1, XRCC2, XRCC3, XRCC4, and oral cancer risk.
    Yang CH; Lin YD; Yen CY; Chuang LY; Chang HW
    OMICS; 2015 Apr; 19(4):238-47. PubMed ID: 25831063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. c-Myc activates BRCA1 gene expression through distal promoter elements in breast cancer cells.
    Chen Y; Xu J; Borowicz S; Collins C; Huo D; Olopade OI
    BMC Cancer; 2011 Jun; 11():246. PubMed ID: 21668996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homologous recombination deficiency leads to profound genetic instability in cells derived from Xrcc2-knockout mice.
    Deans B; Griffin CS; O'Regan P; Jasin M; Thacker J
    Cancer Res; 2003 Dec; 63(23):8181-7. PubMed ID: 14678973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human synaptobrevin-like 1 gene basal transcription is regulated through the interaction of selenocysteine tRNA gene transcription activating factor-zinc finger 143 factors with evolutionary conserved cis-elements.
    Di Leva F; Ferrante MI; Demarchi F; Caravelli A; Matarazzo MR; Giacca M; D'Urso M; D'Esposito M; Franzé A
    J Biol Chem; 2004 Feb; 279(9):7734-9. PubMed ID: 14672948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The egr-1 gene is induced by DNA-damaging agents and non-genotoxic drugs in both normal and neoplastic human cells.
    Quiñones A; Dobberstein KU; Rainov NG
    Life Sci; 2003 May; 72(26):2975-92. PubMed ID: 12706485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.